Skin Longevity Beyond Anti-Aging: Biological Age, Functional Resilience, and the Challenge of Scientific Validation

Skin longevity is increasingly invoked to describe cosmetic and dermatological interventions targeting processes associated with biological aging rather than appearance alone. Yet the evidentiary boundary between improved cosmetic appearance, altered molecular biomarkers, restored tissue function, and genuine modification of the aging trajectory remains poorly defined. This critical perspective examines selected peer-reviewed research available through 24 October 2026, focusing on skin-specific epigenetic clocks, topical urolithin A, integrated models of cutaneous aging, and the broader validation of epigenetic biomarkers. Recent skin-clock research demonstrates that methylation signatures can distinguish associations with environmental exposure from more age-related signals, but such discrimination does not validate biological age reversal. Studies of topical urolithin A connect mechanistic observations in skin models with short-term randomized clinical outcomes, while leaving long-term functional longevity unestablished. We propose a conceptual three-domain validation approach combining mechanistic plausibility, skin-specific functional endpoints, and longitudinal clinical outcomes, with assessment of reproducibility, safety, and conflicts of interest. This is a narrative critical perspective, not a systematic review or evidence-based clinical guideline. Skin longevity may become a scientifically useful framework if its claims are tied to meaningful tissue function and durable outcomes rather than to isolated biomarkers or marketing terminology.